Il tuo browser è obsoleto
Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.
Si, sono un operatore sanitario
Note: Ai sensi e per gli effetti dell’Art. 76 D.P.R. 445/2000 consapevole della responsabilità e delle conseguenze civili e penali previste in caso di dichiarazioni mendaci e/o formazione od uso di atti falsi, nonché in caso di esibizione atti contenenti dati non più corrispondenti a verità e consapevole altresì che qualora emerga la non veridicità del contenuto della presente decadranno i benefici per i quali la stessa è rilasciata confermo di essere un OPERATORE SANITARIO.
I contenuti presenti in questo sito contengono informazioni rivolte agli operatori sanitari, in quanto si riferiscono a prodotti rientranti nella categoria dei dispositivi medici che richiedono l’impiego o l’intervento da parte di professionisti del settore medico-sanitario.
Our enabling technologies help you perform sinus and skull base surgery using powered ENT instruments, surgical navigation systems, and balloon sinus surgery tools. Through innovative technology integration, we bring Surgical Synergy™ to your OR-- facilitating operative efficiency, value, and outcomes.
Nearly 29 million Americans suffer from chronic rhinosinusitis,1 with more than 500,000 sinus surgeries performed annually.2
Chronic rhinosinusitis can have significant effects on health and quality of life -- more disabling than angina, congestive heart failure, and back pain.3
Annual direct costs to society are $4.3 billion,4 and when medical therapy fails, endoscopic sinus surgery is the treatment of choice.3
The goal of sinus surgery is to restore ventilation and drainage while preserving mucosa. Powered sinus surgery with a microdebrider has several benefits compared to surgery with manual instruments alone:
Medtronic offers hands-on training with powered ENT instruments, surgical navigation, nerve monitors, and more. Register for courses.
View the ENT Product Catalog for all sinus surgery products.
*Antibacterial effectiveness only applies to NovaShield. In vitro efficacy is not correlated to clinical effectiveness.
Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for US adults: National Health Interview Survey, 2012. National Center for Health Statistics.Vital Health Stat. 2014; 10(260).
Smith TL, Litvack JR, Hwang PH, et al. Determinants of outcomes of sinus surgery: A multi-institutional prospective cohort study. Otolaryngology–HNS. 2010; 142:55-63.
Khalid AN, Quraishi SA, Kenney DW. Long-term quality of life measures after functional endoscopic sinus surgery. Am J Rhin. 2004; 18:131–136.
Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. May 2004; 113(5):3-5.
Bhattacharyya N. Progress in surgical management of chronic rhinosinusitis and nasal polyposis. Allergy Asthma Rep. 2007; 7(3):216-220.
Cornet ME, Reinartz SM, Georgalas C, et al. The microdebrider, a step forward or an expensive gadget? Rhinology. 2012; 50:191-198.
Saafan ME, Rageb SM, Albirmawy OA, et al. Powered versus conventional endoscopic sinus surgery instruments in management of sinonasal polyposis. Eur Arch Otorhinolaryngol. 2013; 270(1):149-155. DOI: 10.1007/s00405-012-1969-8. E-pub April 10, 2012.
Krouse JH and Christmas DA. Powered instrumentation in functional endoscopic sinus surgery II: a comparative study. ENT Journal. 1996; 75(1): 42-45.
Liu C-M, Tan C-D, Lee F-P, Lin K-N, Huang H-M. Microdebrider-assisted versus radiofrequency-assisted inferior turbinoplasty. Laryngoscope. 2009;119:414-418.
Chen Y-L, Liu C-M, Huang H-M. Comparison of microdebrider-assisted inferior turbinoplasty and submucosal resection for children with hypertrophic inferior turbinates. Intl J Ped Otorhinolaryn. 2007; 71: 921-927.
Chen Y-L, Tan C-T, Huang H-M. Long-term efficacy of microdebrider-assisted inferior turbinoplasty with lateralization for hypertrophic inferior turbinates in patients with perennial allergic rhinitis. Laryngoscope. 2008; 118: 1270-1274.
Haruna S, Otori N, Moriyama H, Kamio M. Endoscopic transnasal transethmosphenoidal approach for pituitary tumors: assessment of technique and postoperative findings of nasal and paranasal cavities. Auris Nasus Larynx. 2007; 34:57-63.
Jho H-D. Endoscopic transsphenoidal tumor surgery. Oper Tech Neurosurg. 2002; 5(4):218-225.
Setty P, Volkov AA, D'Andrea KP, Pieper DR. Endoscopic vascular decompression for the treatment of trigeminal neuralgia: clinical outcomes and technical note. World Neurosurg. 2014; 81(3-4):603-608. doi.org/10.1016/j.wneu.2013.10.036
Ku PK-M, Pak MW, van Hasselt CA. Ann Coll Surg HK. 2002; 6:83-86.
Gross CW, Becker DG. Instrumentation in endoscopic sinus surgery. Oper Tech Otolaryngol Head Neck Surg. 1996; 7(3):236-241.
Lui WM, Leung GKK, Hui Y, Lee KK, Fan YW. Endonasal endoscopic removal of growth hormone-secreting pituitary adenomas. HKMJ. 2001; 7(2):189-192.
Kennedy DW. Functional endoscopic sinus surgery: concepts, surgical indications, and instrumentation. In: Kennedy DW, Bolger WE, Zinreich SJ, eds. Diseases of the Sinuses: Diagnosis and Management. 1st ed. Philadelphia, PA: PMPH USA; 2001:197-210.
Bolger WE, Kennedy DW. Surgical complications and postoperative care. In: Kennedy DW, Bolger WE, Zinreich SJ, eds. Diseases of the Sinuses: Diagnosis and Management. 1st ed. Philadelphia, PA: PMPH USA; 2001:303-316.
Wolcott RD, Rumbaugh KP, James G, et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care. 2010; 19(8):320-328.
Lo W-C, Liao L-J, Wang C-T, Cheng P-W. Powered saline irrigation is useful for endoscopic removal of fungus balls in maxillary sinuses: Our experience in fifty patients. Clin Otolaryngol. 2013; 38:157-165.
Berlucchi M, Castelnuovo P, Vincenzi A, Morra B, Pasquini E. Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study. Eur Arch Otorhinolaryngol. 2009; 266(6):839-45.
Franklin JH and Wright ED. Randomized, controlled, study of absorbable nasal packing on outcomes of surgical treatment of rhinosinusitis with polyposis. Am J Rhinol. 2007; 21:214-217. doi: 10.2500/ajr.2007.21.3011.
Transnasal skull base surgery typically involves both a neurosurgeon and an ENT surgeon. In this difficult and highly vascular area, maximum visualization and access are key.
Medtronic's innovative products and integrated technologies can help you address the unique challenges of transnasal skull base surgery.
Haruna S, Otori N, Moriyama H, Kamio M. Endoscopic transnasal transethmosphenoidal approach for pituitary tumors: assessment of technique and postoperative findings of nasal and paranasal cavities. Auris Nasus Larynx. 2007; 34:57-63.
Jho H-D. Endoscopic transsphenoidal tumor surgery. Oper Tech Neurosurg. 2002; 5(4):218-225.
Setty P, Volkov AA, D'Andrea KP, Pieper DR. Endoscopic vascular decompression for the treatment of trigeminal neuralgia: clinical outcomes and technical note. World Neurosurg. 2014; 81(3-4):603-608. http://dx.doi.org/10.1016/j.wneu.2013.10.036
Ku PK-M, Pak MW, van Hasselt CA. Ann Coll Surg HK. 2002; 6:83-86.
Gross CW, Becker DG. Instrumentation in endoscopic sinus surgery. Oper Tech Otolaryngol Head Neck Surg. 1996; 7(3):236-241.
Lui WM, Leung GKK, Hui Y, Lee KK, Fan YW. Endonasal endoscopic removal of growth hormone-secreting pituitary adenomas. HKMJ. 2001; 7(2):189-192.
Kennedy DW. Functional endoscopic sinus surgery: concepts, surgical indications, and instrumentation. In: Kennedy DW, Bolger WE, Zinreich SJ, eds. Diseases of the Sinuses: Diagnosis and Management. 1st ed. Philadelphia, PA: PMPH USA; 2001:197-210.
Bolger WE, Kennedy DW. Surgical complications and postoperative care. In: Kennedy DW, Bolger WE, Zinreich SJ, eds. Diseases of the Sinuses: Diagnosis and Management. 1st ed. Philadelphia, PA: PMPH USA; 2001:303-316.
Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.